Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

U.S. to donate 500 million Pfizer vaccine doses to the world -sources

Published 06/09/2021, 03:03 PM
Updated 06/09/2021, 08:31 PM
© Reuters. FILE PHOTO: A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
PFE
-
MRNA
-

By Trevor Hunnicutt and Carl O'Donnell

WASHINGTON (Reuters) -The Biden administration plans to donate 500 million Pfizer (NYSE:PFE) coronavirus vaccine doses to nearly 100 countries over the next two years, three sources familiar with the matter told Reuters on Wednesday.

The United States is likely to distribute 200 million shots this year and another 300 million in the first half of next year to 92 lower-income countries and the African Union, they said.

The donations will go through the COVAX vaccine program that distributes COVID-19 shots to low- and middle-income countries. The program is led by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI).

GAVI did not respond to a request for comment.

U.S. President Joe Biden will announce the deal on Thursday at the Group of Seven meeting of the world's wealthiest countries in Britain, one of the people said.

The deal was negotiated over the past four weeks by White House COVID-19 response coordinator Jeff Zients and the coronavirus task force team, one of the sources said.

CNBC reported on Wednesday that the United States is also talking with Moderna (NASDAQ:MRNA) Inc about buying some of its shots to donate to other countries.

A Moderna spokesperson said the company is interested in possibly providing the U.S. government with COVID-19 shots to give to low- and middle-income countries but declined to comment on any discussions.

The White House and Pfizer declined to comment.

The U.S. president told reporters before boarding Air Force One for Britain that he had a global vaccine strategy and would be announcing it but did not offer details.

The White House has been under mounting pressure to boost donations of COVID-19 shots to other countries.

The United States has given at least one shot to around 64% of its adult population and has begun vaccinating adolescents, while other countries like Brazil and India are struggling to get desperately needed doses.

"This action sends an incredibly powerful message about America’s commitment to helping the world fight this pandemic," said Tom Hart, acting chief executive of The ONE Campaign, a nonprofit working to end extreme poverty and preventable disease by 2030.

The administration is also using the U.S. vaccine supply as a tool to counter Chinese and Russian vaccine diplomacy.

The Biden administration had said it would share 80 million vaccine doses worldwide by the end of June. The White House earlier this year also pledged $4 billion to COVAX and urged other countries to boost donations as well.

Pfizer has said it expects to produce as many as 3 billion COVID-19 shots in 2021 and upwards of 4 billion next year.

© Reuters. FILE PHOTO: A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

The New York Times reported that the United States will buy the doses at a "not-for-profit" price, citing people familiar with the deal. They also reported that Pfizer CEO Albert Bourla will accompany Biden during the announcement.

The agreement is in addition to the 300 million shots the United States has already purchased from Pfizer and brings the total number of Pfizer/BioNTech shots purchased by the United States to 800 million, the Times said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.